Method for reducing incidence of in-stent restenosis and special stainless steel material thereof

A stent material, stainless steel technology, applied in stents, medical science, surgery, etc., can solve the problem of appropriate dosage half-life, achieve the effect of reducing restenosis in the stent and the incidence of restenosis

Active Publication Date: 2013-07-24
蔻沛斯蒂(浙江)医疗器械有限公司
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Surface-modified stents such as gene coating and endothelialization treatment are still in the research stage, and there are still problems such as whether the dose of radiochemically treated stents is controllable and whether the half-life is appropriate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for reducing incidence of in-stent restenosis and special stainless steel material thereof
  • Method for reducing incidence of in-stent restenosis and special stainless steel material thereof
  • Method for reducing incidence of in-stent restenosis and special stainless steel material thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0022] In this embodiment, different contents of copper elements are added to the medical 316L stainless steel, the chemical composition is shown in Table 1, and different heat treatment processes are used, see Table 2 for details. For the new 316L copper-containing stainless steel material for coronary artery stents that can effectively reduce the incidence of in-stent restenosis, the conventional medical 316L stainless steel was used as the control material, and flow cytometry detection, dynamic coagulation detection and MTT biocompatibility were carried out. The experimental results are shown in Tables 2 and 3.

[0023] Table 1 Chemical composition of 316L type copper-containing stainless steel (weight%)

[0024]

[0025] Flow Cytometry:

[0026] The apoptosis rate of 316L copper-containing stainless steel on endothelial cells (HUVEC) and vascular smooth muscle cells (VSCMs) was measured by flow cytometry. This method can objectively evaluate the effect of copper-contai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of coronary stents, specifically to a method for reducing the incidence of in-stent restenosis and its special stainless steel material. The method of the invention adds a proper amount of copper element (2.0-6.0% by weight) into the common clinical coronary stent material 316L stainless steel, and conducts special heat treatment so as to make the copper separated in a copper-rich phase out of the stainless steel substrate. The stent is enabled to continuously release trace amounts of copper ions in a clinical environment, and the coronary stent is endowed with an anti-restenotic function, thus effectively reducing the incidence of restenosis after stent implantation. With a unique function of reducing the in-stent restenosis phenomenon caused by stent implantation into a coronary artery, the 316L type copper-containing stainless steel of the invention is conducive to solve clinical problems such as high incidence of in-stent restenosis after implantation of existing stainless steel coronary stents, and can be applied in coronary stents and other clinical medicine fields, thus providing a new idea and material basis for development and application of coronary stents.

Description

technical field [0001] The present invention relates to the field of coronary artery stents, in particular to a method for effectively reducing the incidence of in-stent restenosis and a new 316L type copper-containing stainless steel material for special coronary artery stents, which has the ability to effectively reduce the occurrence of stents after implantation of stainless steel coronary artery stents The unique function of internal restenosis can be applied in medical clinical fields such as coronary artery stent implantation. Background technique [0002] Heart disease is one of the primary causes of human health threats, and now about 15 million patients with coronary heart disease worldwide need advanced percutaneous transluminal coronary angioplasty (PTCA). PTCA has the advantages of minimal trauma, high efficiency and easy repeatability, so it has become a rapidly developing new method for the treatment of coronary heart disease caused by cardiovascular stenosis. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C22C38/44C22C38/42A61L31/02A61L31/14A61F2/82
Inventor 任玲杨柯
Owner 蔻沛斯蒂(浙江)医疗器械有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap